ABO, MNSs and Rhesus Blood Groups in Bladder Cancer
- 1 August 1983
- journal article
- research article
- Published by Wiley in British Journal of Urology
- Vol. 55 (4) , 377-381
- https://doi.org/10.1111/j.1464-410x.1983.tb03326.x
Abstract
Data are presented on a group of cases of primary carcinoma of the bladder detailing their ABO, MNSs and rhesus blood antigenic phenotypes. Differences, either between all cases and controls or between particular stages of presentation and controls, were found in the ABO red cell system as well as the MNSs red cell system. In the case of the ABO system an excess of the A gene is present, but detailed study shows this to be only in patients with T1 and T2 tumors. No excess was seen in patients with carcinoma in situ or T3 or T4 stage disease. The S gene of the MNSs system is also in excess in cases of bladder cancer.This publication has 16 references indexed in Scilit:
- Ten genetic polymorphisms in bladder cancer.Journal of Medical Genetics, 1983
- ROLE OF N-ACETYLTRANSFERASE PHENOTYPES IN BLADDER CARCINOGENESIS: A PHARMACOGENETIC EPIDEMIOLOGICAL APPROACH TO BLADDER CANCERThe Lancet, 1982
- Blood group antigens and bladder cancer.BMJ, 1982
- Synthesis of ABH Blood Group Substances in Bladder TurnoursBritish Journal of Urology, 1981
- The epidemiology of bladder cancer in West Yorkshire. A preliminary report on non-occupational aetiologiesCarcinogenesis: Integrative Cancer Research, 1981
- Survival of Transitional Cell Carcinima Casesf in 2 Yorkshire CentresBritish Journal of Urology, 1980
- Genetic Associations of Transitional Cell CarcinomaBritish Journal of Urology, 1979
- Über das gegensätzliche Verhalten der Blutgruppen A1und A2Deutsche Medizinische Wochenschrift (1946), 1962
- BLOOD-GROUPS IN RELATION TO MALIGNANT DISEASESThe Lancet, 1956